Metabolism in Human Mesenchymal Stromal Cells: A Missing Link Between hMSC Biomanufacturing and Therapy?
暂无分享,去创建一个
Teng Ma | Xuegang Yuan | T. Logan | T. Ma | Xuegang Yuan | Timothy M. Logan
[1] Sergio Romagnani,et al. Role for Interferon‐γ in the Immunomodulatory Activity of Human Bone Marrow Mesenchymal Stem Cells , 2006 .
[2] H. Koo,et al. Enhanced Immunosuppressive Properties of Human Mesenchymal Stem Cells Primed by Interferon-γ , 2018, EBioMedicine.
[3] A. Wagers,et al. Stem cell aging: mechanisms, regulators and therapeutic opportunities , 2014, Nature Medicine.
[4] B. Shen,et al. A critical role of IFNγ in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1 , 2008, Cell Research.
[5] T. Logan,et al. Density‐Dependent Metabolic Heterogeneity in Human Mesenchymal Stem Cells , 2015, Stem cells.
[6] R. Tuan,et al. Characterization of bone marrow-derived mesenchymal stem cells in aging. , 2015, Bone.
[7] T. Ma,et al. Three-dimensional aggregates of mesenchymal stem cells: cellular mechanisms, biological properties, and applications. , 2014, Tissue engineering. Part B, Reviews.
[8] T. Ma,et al. Aggregation of Culture Expanded Human Mesenchymal Stem Cells in Microcarrier-based Bioreactor. , 2018, Biochemical engineering journal.
[9] M. Yen,et al. Brief Report—Human Embryonic Stem Cell‐Derived Mesenchymal Progenitors Possess Strong Immunosuppressive Effects Toward Natural Killer Cells as Well as T Lymphocytes , 2009, Stem cells.
[10] Simon C Watkins,et al. Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs , 2015, Nature Communications.
[11] Todd C McDevitt,et al. Pre-conditioning mesenchymal stromal cell spheroids for immunomodulatory paracrine factor secretion. , 2014, Cytotherapy.
[12] L. Zhang,et al. Mesenchymal stem cells: a double-edged sword in regulating immune responses , 2012, Cell Death and Differentiation.
[13] Wei Cao,et al. Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications , 2014, Nature Immunology.
[14] Matthew G. Vander Heiden,et al. Metabolic targets for cancer therapy , 2013, Nature Reviews Drug Discovery.
[15] Ling Wei,et al. Prolyl hydroxylase inhibitor dimethyloxalylglycine enhances mesenchymal stem cell survival , 2009, Journal of cellular biochemistry.
[16] J. Montesinos,et al. Immunoregulation by Mesenchymal Stem Cells: Biological Aspects and Clinical Applications , 2015, Journal of immunology research.
[17] N. Larochette,et al. Human Mesenchymal Stem Cell Failure to Adapt to Glucose Shortage and Rapidly Use Intracellular Energy Reserves Through Glycolysis Explains Poor Cell Survival After Implantation , 2018, Stem cells.
[18] S. Lim,et al. Immune regulatory targets of mesenchymal stromal cell exosomes/small extracellular vesicles in tissue regeneration. , 2018, Cytotherapy.
[19] L. Cantley,et al. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.
[20] T. Logan,et al. Metabolic Reconfiguration Supports Reacquisition of Primitive Phenotype in Human Mesenchymal Stem Cell Aggregates , 2017, Stem cells.
[21] E. Andreeva,et al. IFN‐gamma priming of adipose‐derived stromal cells at “physiological” hypoxia , 2018, Journal of cellular physiology.
[22] Gerard Pasterkamp,et al. Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury. , 2013, Stem cell research.
[23] Cláudia Lobato da Silva,et al. Ex vivo expansion of human mesenchymal stem cells: A more effective cell proliferation kinetics and metabolism under hypoxia , 2009, Journal of cellular physiology.
[24] Nikolay Bazhanov,et al. Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties , 2010, Proceedings of the National Academy of Sciences.
[25] F. Barry,et al. IFN-gamma and TNF-alpha differentially regulate immunomodulation by murine mesenchymal stem cells. , 2007, Immunology letters.
[26] J. Galipeau,et al. Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities. , 2018, Cell stem cell.
[27] Xiaobing Fu,et al. Hypoxia Regulates the Therapeutic Potential of Mesenchymal Stem Cells Through Enhanced Autophagy , 2015, The international journal of lower extremity wounds.
[28] B. Blanco,et al. The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes , 2008, Haematologica.
[29] C. Ahn,et al. Immunosuppressive mechanisms of embryonic stem cells and mesenchymal stem cells in alloimmune response. , 2011, Transplant immunology.
[30] R. Weinberg,et al. Asymmetric apportioning of aged mitochondria between daughter cells is required for stemness , 2015, Science.
[31] V. Gori,et al. Human platelet lysate in mesenchymal stromal cell expansion according to a GMP grade protocol: a cell factory experience , 2018, Stem Cell Research & Therapy.
[32] I. Sakaida,et al. Analysis of Metabolomic Changes in Mesenchymal Stem Cells on Treatment with Desferrioxamine as a Hypoxia Mimetic Compared with Hypoxic Conditions , 2018, Stem cells.
[33] J. Mosca,et al. Characterization and functionality of cell surface molecules on human mesenchymal stem cells. , 2003, Journal of biomedical science.
[34] T. Gajewski,et al. Glucose Availability Regulates IFN-γ Production and p70S6 Kinase Activation in CD8+ Effector T Cells1 , 2005, The Journal of Immunology.
[35] S. Andò,et al. Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: Connecting TGF-β signaling with “Warburg-like” cancer metabolism and L-lactate production , 2012, Cell cycle.
[36] D. Prockop,et al. Human Mesenchymal Stem/Stromal Cells Cultured as Spheroids are Self‐activated to Produce Prostaglandin E2 that Directs Stimulated Macrophages into an Anti‐inflammatory Phenotype , 2012, Stem cells.
[37] R. Dewey,et al. Effect of TGF‐β1 Stimulation on the Secretome of Human Adipose‐Derived Mesenchymal Stromal Cells , 2015, Stem cells translational medicine.
[38] R. Borojevic,et al. Stromal-vascular fraction content and adipose stem cell behavior are altered in morbid obese and post bariatric surgery ex-obese women , 2015, Stem Cell Research & Therapy.
[39] J. Montero,et al. Hypoxia Inducible Factor‐1α Potentiates Jagged 1‐Mediated Angiogenesis by Mesenchymal Stem Cell‐Derived Exosomes , 2017, Stem cells.
[40] L. Lerman,et al. Mesenchymal stem cell-derived extracellular vesicles for kidney repair: current status and looming challenges , 2017, Stem Cell Research & Therapy.
[41] F. Barry,et al. Mesenchymal stromal cell therapy: progress in manufacturing and assessments of potency. , 2019, Cytotherapy.
[42] Huiyong Shen,et al. Autophagy Improves the Immunosuppression of CD4+ T Cells by Mesenchymal Stem Cells Through Transforming Growth Factor‐β1 , 2016, Stem cells translational medicine.
[43] Wei Zhang,et al. HIF-1-mediated production of exosomes during hypoxia is protective in renal tubular cells. , 2017, American journal of physiology. Renal physiology.
[44] M. Alini,et al. Concise Review: Bone Marrow‐Derived Mesenchymal Stem Cells Change Phenotype Following In Vitro Culture: Implications for Basic Research and the Clinic , 2014, Stem cells.
[45] A. Terzic,et al. Metabolic plasticity in stem cell homeostasis and differentiation. , 2012, Cell stem cell.
[46] Joshua A. Zimmermann,et al. Enhanced Immunosuppression of T Cells by Sustained Presentation of Bioactive Interferon‐γ Within Three‐Dimensional Mesenchymal Stem Cell Constructs , 2016, Stem cells translational medicine.
[47] W. Fibbe,et al. Multipotent stromal cells skew monocytes towards an anti-inflammatory function: the link with key immunoregulatory molecules , 2013, Haematologica.
[48] Minjuan Wu,et al. N-Acetylcysteine-Pretreated Human Embryonic Mesenchymal Stem Cell Administration Protects Against Bleomycin-Induced Lung Injury , 2013, The American journal of the medical sciences.
[49] E. Giannoni,et al. Time-Dependent Stabilization of Hypoxia Inducible Factor-1α by Different Intracellular Sources of Reactive Oxygen Species , 2012, PloS one.
[50] S. Perez,et al. Interactions Between Human Mesenchymal Stem Cells and Natural Killer Cells , 2006, Stem cells.
[51] E. Adashi,et al. Interleukin (IL)-1beta increases glucose uptake and induces glycolysis in aerobically cultured rat ovarian cells: evidence that IL-1beta may mediate the gonadotropin-induced midcycle metabolic shift. , 1997, Endocrinology.
[52] M. Soleimani,et al. Immunomodulatory effects of mesenchymal stem cell–derived exosomes on experimental type‐1 autoimmune diabetes , 2018, Journal of cellular biochemistry.
[53] R. DePinho,et al. Cellular Senescence Minireview Mitotic Clock or Culture Shock? , 2000, Cell.
[54] L. Moretta,et al. Interactions between mesenchymal stem cells and dendritic cells. , 2013, Advances in biochemical engineering/biotechnology.
[55] M. Jeong,et al. Mesenchymal stem cells reciprocally regulate the M1/M2 balance in mouse bone marrow-derived macrophages , 2014, Experimental & Molecular Medicine.
[56] F. Benvenuto,et al. Human mesenchymal stem cells modulate B-cell functions. , 2006, Blood.
[57] C. Carlo-Stella,et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. , 2002, Blood.
[58] V. Lunyak,et al. Adipose stem cells from obese patients show specific differences in the metabolic regulators vitamin D and Gas5 , 2017, Molecular genetics and metabolism reports.
[59] B. Yu,et al. Effects of Mesenchymal Stem Cell-Derived Exosomes on Experimental Autoimmune Uveitis , 2017, Scientific Reports.
[60] J. Vendrell,et al. Obesity and Type 2 Diabetes Alters the Immune Properties of Human Adipose Derived Stem Cells , 2016, Stem cells.
[61] T. Logan,et al. Commitment to Aerobic Glycolysis Sustains Immunosuppression of Human Mesenchymal Stem Cells , 2018, Stem cells translational medicine.
[62] J. Ankrum,et al. Manufacturing of primed mesenchymal stromal cells for therapy , 2019, Nature Biomedical Engineering.
[63] F. Sbrana,et al. The Role of Autophagy in the Maintenance of Stemness and Differentiation of Mesenchymal Stem Cells , 2016, Stem Cell Reviews and Reports.
[64] Yaping Zhang,et al. Up-regulation of immunomodulatory effects of mouse bone-marrow derived mesenchymal stem cells by tetrahydrocannabinol pre-treatment involving cannabinoid receptor CB2 , 2016, Oncotarget.
[65] T. Du,et al. Microvesicles derived from human Wharton’s Jelly mesenchymal stromal cells ameliorate renal ischemia-reperfusion injury in rats by suppressing CX3CL1 , 2014, Stem Cell Research & Therapy.
[66] A. Vepsäläinen,et al. Mitochondrial function and energy metabolism in umbilical cord blood- and bone marrow-derived mesenchymal stem cells. , 2012, Stem cells and development.
[67] Lei Chen,et al. Conditioned Medium from Hypoxic Bone Marrow-Derived Mesenchymal Stem Cells Enhances Wound Healing in Mice , 2014, PloS one.
[68] D. Pennington,et al. Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease. , 2014, Biochimica et biophysica acta.
[69] S. Giannotti,et al. Pooled human serum: A new culture supplement for bioreactor-based cell therapies. Preliminary results. , 2018, Cytotherapy.
[70] F. Segal,et al. A CHARACTERIZATION OF FIBRANT SEGAL CATEGORIES , 2006, math/0603400.
[71] R. Willemze,et al. Mesenchymal Stem Cells Inhibit Generation and Function of Both CD34+-Derived and Monocyte-Derived Dendritic Cells1 , 2006, The Journal of Immunology.
[72] Yufang Shi,et al. TGF-β Promotes Immune Responses in the Presence of Mesenchymal Stem Cells , 2014, The Journal of Immunology.
[73] G. Vunjak‐Novakovic,et al. Hypoxia and stem cell‐based engineering of mesenchymal tissues , 2009, Biotechnology progress.
[74] Bo Kara,et al. Expansion, harvest and cryopreservation of human mesenchymal stem cells in a serum‐free microcarrier process , 2015, Biotechnology and bioengineering.
[75] H. Northoff,et al. Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cells , 2013, BMC Medicine.
[76] T. Ma,et al. Size-Dependent Cortical Compaction Induces Metabolic Adaptation in Mesenchymal Stem Cell Aggregates. , 2019, Tissue engineering. Part A.
[77] Q. Tan,et al. Potential roles of IL-1 subfamily members in glycolysis in disease. , 2018, Cytokine & growth factor reviews.
[78] P. Robbins,et al. Regulation of immune responses by extracellular vesicles , 2014, Nature Reviews Immunology.
[79] D. Hommes,et al. Intraluminal Injection of Mesenchymal Stromal Cells in Spheroids Attenuates Experimental Colitis. , 2016, Journal of Crohn's & colitis.
[80] R. Zhao,et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. , 2008, Cell Stem Cell.
[81] E. Andreeva,et al. Tissue-Related Hypoxia Attenuates Proinflammatory Effects of Allogeneic PBMCs on Adipose-Derived Stromal Cells In Vitro , 2016, Stem cells international.
[82] B. Gharibi,et al. Inhibition of Akt/mTOR Attenuates Age‐Related Changes in Mesenchymal Stem Cells , 2014, Stem cells.
[83] W. Fibbe,et al. Adipose Tissue‐Derived Multipotent Stromal Cells Have a Higher Immunomodulatory Capacity Than Their Bone Marrow‐Derived Counterparts , 2013, Stem cells translational medicine.
[84] T. Logan,et al. Gas chromatography-mass spectrometry analysis of human mesenchymal stem cell metabolism during proliferation and osteogenic differentiation under different oxygen tensions. , 2014, Journal of biotechnology.
[85] Meifeng Xu,et al. Exosomes secreted from GATA-4 overexpressing mesenchymal stem cells serve as a reservoir of anti-apoptotic microRNAs for cardioprotection. , 2015, International journal of cardiology.
[86] Yufei Wang,et al. Effects of Hypoxia on the Immunomodulatory Properties of Human Gingiva–Derived Mesenchymal Stem Cells , 2015, Journal of dental research.
[87] R. DePinho,et al. Cellular senescence: mitotic clock or culture shock? , 2000, Cell.
[88] D. Prockop,et al. Dynamic compaction of human mesenchymal stem/precursor cells into spheres self‐activates caspase‐dependent IL1 signaling to enhance secretion of modulators of inflammation and immunity (PGE2, TSG6, and STC1) , 2013, Stem cells.
[89] B. Thébaud,et al. Effect of Fatty Acids on Human Bone Marrow Mesenchymal Stem Cell Energy Metabolism and Survival , 2015, PloS one.
[90] Joost D de Bruijn,et al. The metabolism of human mesenchymal stem cells during proliferation and differentiation , 2011, Journal of cellular physiology.
[91] L. Lerman,et al. Obesity‐induced mitochondrial dysfunction in porcine adipose tissue‐derived mesenchymal stem cells , 2018, Journal of cellular physiology.
[92] Shiyong Li,et al. Oxidative preconditioning promotes bone marrow mesenchymal stem cells migration and prevents apoptosis , 2009, Cell biology international.
[93] L. Moretta,et al. Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. , 2006, Blood.
[94] M. Toungouz,et al. Influence of inflammation on the immunological profile of adult-derived human liver mesenchymal stromal cells and stellate cells. , 2015, Cytotherapy.
[95] Jon A. Rowley,et al. Peak MSC—Are We There Yet? , 2018, Front. Med..
[96] Hyun Ho Hwang,et al. Small hypoxia-primed mesenchymal stem cells attenuate graft-versus-host disease , 2018, Leukemia.
[97] H. Fan,et al. Pre-treatment with IL-1β enhances the efficacy of MSC transplantation in DSS-induced colitis , 2012, Cellular and Molecular Immunology.
[98] M. Yen,et al. Interleukin-25 Mediates Transcriptional Control of PD-L1 via STAT3 in Multipotent Human Mesenchymal Stromal Cells (hMSCs) to Suppress Th17 Responses , 2015, Stem cell reports.
[99] Clotilde Théry,et al. Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication , 2019, Nature Cell Biology.
[100] N. Walker,et al. Equine mesenchymal stem cells inhibit T cell proliferation through different mechanisms depending on tissue source. , 2014, Stem cells and development.
[101] R. Najafi,et al. Deferoxamine preconditioning potentiates mesenchymal stem cell homing in vitro and in streptozotocin-diabetic rats , 2013, Expert opinion on biological therapy.
[102] G. Daley,et al. Stem cell metabolism in tissue development and aging , 2013, Development.
[103] Chii‐Ming Lee,et al. Prostaglandin E2 Potentiates Mesenchymal Stem Cell–Induced IL-10+IFN-γ+CD4+ Regulatory T Cells To Control Transplant Arteriosclerosis , 2013, The Journal of Immunology.
[104] A. Zapata,et al. Overexpression of hypoxia-inducible factor 1 alpha improves immunomodulation by dental mesenchymal stem cells , 2017, Stem Cell Research & Therapy.
[105] Ping Chen,et al. Hypoxia Precondition Promotes Adipose-Derived Mesenchymal Stem Cells Based Repair of Diabetic Erectile Dysfunction via Augmenting Angiogenesis and Neuroprotection , 2015, PloS one.
[106] M. Warr,et al. Autophagy maintains the metabolism and function of young and old (hematopoietic) stem cells , 2017, Nature.
[107] Feng Zhao,et al. Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells. , 2007, Biochemical and biophysical research communications.
[108] Teng Ma,et al. Metabolic regulation of mesenchymal stem cell in expansion and therapeutic application , 2015, Biotechnology progress.
[109] H. Hackstein,et al. Immunosuppressive capacity of mesenchymal stem cells correlates with metabolic activity and can be enhanced by valproic acid , 2017, Stem Cell Research & Therapy.
[110] J. Grinyó,et al. Immunomodulatory Effect of Mesenchymal Stem Cells on B Cells , 2012, Front. Immun..
[111] K. English,et al. Jagged-1 is required for the expansion of CD4+ CD25+ FoxP3+ regulatory T cells and tolerogenic dendritic cells by murine mesenchymal stromal cells , 2015, Stem Cell Research & Therapy.
[112] Xiujun Li,et al. TGF‐β3‐induced miR‐494 inhibits macrophage polarization via suppressing PGE2 secretion in mesenchymal stem cells , 2016, FEBS letters.
[113] S. Lang,et al. Interferon-gamma and tumor necrosis factor-alpha differentially affect cytokine expression and migration properties of mesenchymal stem cells. , 2010, Stem cells and development.
[114] X. Luan,et al. Interferon-γ and tumor necrosis factor-α promote the ability of human placenta-derived mesenchymal stromal cells to express programmed death ligand-2 and induce the differentiation of CD4(+)interleukin-10(+) and CD8(+)interleukin-10(+)Treg subsets. , 2015, Cytotherapy.
[115] B. Nilsson,et al. Cryopreserved Mesenchymal Stromal Cells Display Impaired Immunomodulatory and Therapeutic Properties ? , 2022 .
[116] Lorenzo Galluzzi,et al. Metabolic control of cell death , 2014, Science.
[117] A. Dopazo,et al. Culture of human mesenchymal stem cells at low oxygen tension improves growth and genetic stability by activating glycolysis , 2011, Cell Death and Differentiation.
[118] R. Wenger,et al. Frequently asked questions in hypoxia research , 2015, Hypoxia.
[119] M. Yen,et al. Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials , 2016, Journal of Biomedical Science.
[120] D. Shum-Tim,et al. Mitochondrial Oxidative Stress Reduces the Immunopotency of Mesenchymal Stromal Cells in Adults With Coronary Artery Disease , 2017, Circulation research.
[121] Hongwei Liang,et al. Pyruvate kinase type M2 promotes tumour cell exosome release via phosphorylating synaptosome-associated protein 23 , 2017, Nature Communications.
[122] T. Ma,et al. Compaction, fusion, and functional activation of three-dimensional human mesenchymal stem cell aggregate. , 2015, Tissue engineering. Part A.
[123] Ivan Martin,et al. International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials. , 2016, Cytotherapy.
[124] M. Toungouz,et al. Immune-Related Antigens, Surface Molecules and Regulatory Factors in Human-Derived Mesenchymal Stromal Cells: The Expression and Impact of Inflammatory Priming , 2012, Stem Cell Reviews and Reports.
[125] Marta M. Silva,et al. Bioprocess integration for human mesenchymal stem cells: From up to downstream processing scale-up to cell proteome characterization. , 2017, Journal of biotechnology.
[126] S. Brandau,et al. Interaction with Mesenchymal Stem Cells Provokes Natural Killer Cells for Enhanced IL-12/IL-18-Induced Interferon-Gamma Secretion , 2014, Mediators of inflammation.
[127] Ruth S. Waterman,et al. A New Mesenchymal Stem Cell (MSC) Paradigm: Polarization into a Pro-Inflammatory MSC1 or an Immunosuppressive MSC2 Phenotype , 2010, PloS one.
[128] Piul S. Rabbani,et al. Microenvironmental cues enhance mesenchymal stem cell-mediated immunomodulation and regulatory T-cell expansion , 2018, PloS one.
[129] B. Sander,et al. Long-term complications, immunologic effects, and role of passage for outcome in mesenchymal stromal cell therapy. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[130] H. Tse,et al. Mesenchymal stem cells and immunomodulation: current status and future prospects , 2016, Cell Death and Disease.
[131] L. Tang,et al. Characterization of bone marrow derived mesenchymal stem cells in suspension , 2012, Stem Cell Research & Therapy.
[132] T. Palomares,et al. Cryopreserved H2O2‐preconditioned human adipose‐derived stem cells exhibit fast post‐thaw recovery and enhanced bioactivity against oxidative stress , 2019, Journal of tissue engineering and regenerative medicine.
[133] R. Cancedda,et al. Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway , 2005, European journal of immunology.
[134] C. Barbas,et al. Altered Metabolic and Stemness Capacity of Adipose Tissue-Derived Stem Cells from Obese Mouse and Human , 2015, PloS one.
[135] F. Barry,et al. IFN-γ and TNF-α differentially regulate immunomodulation by murine mesenchymal stem cells , 2007 .
[136] R. O’Keefe,et al. Distinct metabolic programs induced by TGF-β1 and BMP2 in human articular chondrocytes with osteoarthritis , 2018, Journal of orthopaedic translation.
[137] E. Adashi,et al. Interleukin (IL)-1β Increases Glucose Uptake and Induces Glycolysis in Aerobically Cultured Rat Ovarian Cells: Evidence That IL-1β May Mediate the Gonadotropin-Induced Midcycle Metabolic Shift. , 1997, Endocrinology.